The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 291.50
Bid: 293.50
Ask: 295.00
Change: -10.50 (-3.48%)
Spread: 1.50 (0.511%)
Open: 300.00
High: 304.00
Low: 291.50
Prev. Close: 302.00
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Non-Executive Director

9 Jul 2021 07:00

RNS Number : 6550E
Synthomer PLC
09 July 2021
 

9th July 2021

Synthomer plc

Appointment of Non-Executive Director

Synthomer plc ('Synthomer' or 'the Company') today announces that it has appointed Roberto Gualdoni as a Non-Executive Director. He will join the Board with immediate effect and become a member of the Audit, Remuneration and Nomination Committees. Roberto replaces Just Jansz, who will be stepping down from the Board at the end of August 2021 following nine years' service.

Roberto has considerable chemicals sector experience following more than 25 years at BASF. During that time, he held senior operational roles covering international sales, marketing, procurement and M&A and served on a number of joint venture Boards. His final role at BASF was as President of its Styrenics business, which was carved out as part of a joint venture as Styrolution, and which Roberto led as Chief Executive for three years until 2014.

Roberto is currently Chair of CABB Group, a private speciality chemicals manufacturer, and a member of the Board of Directors of Aerogel Corporation, a private bio-pharma cold-chain services provider. Previously, he has served on the Boards of SABIC, Outokumpu Oyj and Carmeuse.

Caroline Johnstone, Chair of Synthomer, said:

"I am delighted to welcome Roberto to Synthomer's Board. His extensive knowledge of the international chemicals industry, and wealth of Board-level experience, will be enormously valuable as we continue to execute our strategy and invest in future growth. On behalf of the Board, I would also like to thank Just for his considerable contribution to Synthomer over the last nine years."

There are no further matters to be disclosed under LR9.6.13R of the Listing Rules of the UK Listing Authority.

-ENDS-

Enquiries:

Tim Hughes - President, Corporate Development

Tel +44 1279 436211

Charles Armitstead/ Matt Denham - Teneo

Tel +44 7703 330 269/ +44 7825 735 596

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUWSURAAUBRAR
Date   Source Headline
1st Jul 20167:00 amRNSCompletion of acquisition and trading update
31st May 201611:31 amRNSAudit Tender
16th May 20164:17 pmRNSHolding(s) in Company
9th May 201612:31 pmRNSDirector/PDMR Shareholding
28th Apr 20163:11 pmRNSResult of AGM
28th Apr 20167:00 amRNSQ1 Trading update
21st Apr 20161:44 pmRNSHolding(s) in Company
20th Apr 20162:23 pmRNSDirector Declaration
11th Apr 20163:01 pmRNSDirector/PDMR Shareholding
11th Apr 20163:00 pmRNSDirector/PDMR Shareholding
31st Mar 20162:15 pmRNSAnnual Financial Report
21st Mar 20167:00 amRNSAcquisition
21st Mar 20167:00 amRNSDisposal
15th Mar 201612:29 pmRNSHolding(s) in Company
2nd Mar 20167:00 amRNSPreliminary Results for the year ended 31 Dec 2015
10th Feb 20167:00 amRNSFRS 101 Notification
5th Feb 20163:34 pmRNSHolding(s) in Company
5th Feb 20163:13 pmRNSHolding(s) in Company
30th Nov 20153:00 pmRNSHolding(s) in Company
18th Nov 201510:30 amRNSDirector/PDMR Shareholding
6th Nov 20157:00 amRNSQ3 Trading Update
1st Oct 201512:50 pmRNSHolding(s) in Company
13th Aug 201510:05 amRNSHolding(s) in Company
11th Aug 20157:00 amRNSHalf Yearly Results
10th Jul 20152:43 pmRNSDirector/PDMR Shareholding
9th Jul 20159:12 amRNSHolding(s) in Company
7th Jul 20154:21 pmRNSHolding(s) in Company
6th Jul 20153:59 pmRNSHolding(s) in Company
2nd Jul 20157:00 amRNSTrading Update
22nd Jun 20153:51 pmRNSHolding(s) in Company
20th May 20158:57 amRNSHolding(s) in Company
14th May 201510:02 amRNSDirector/PDMR Shareholding
30th Apr 201512:53 pmRNSResult of AGM
30th Apr 201512:46 pmRNSDirectorate Change
30th Apr 20157:00 amRNSQuarter 1 Trading Update
27th Apr 201510:36 amRNSDirectorate Change
21st Apr 20155:16 pmRNSHolding(s) in Company
1st Apr 20158:15 amRNSDirectorate Change
31st Mar 20159:25 amRNSAnnual Financial Report
30th Mar 201510:13 amRNSHolding(s) in Company
27th Mar 201512:53 pmRNSDirector/PDMR Shareholding
23rd Mar 20157:00 amRNSDirectorate Change
19th Mar 201511:53 amRNSDirector Declaration
18th Mar 20154:47 pmRNSDirector/PDMR Shareholding
13th Mar 20159:35 amRNSHolding(s) in Company
27th Feb 20153:06 pmRNSDirector/PDMR Shareholding
27th Feb 20153:05 pmRNSDirector/PDMR Shareholding
26th Feb 20157:01 amRNSFinal Results
20th Jan 20151:58 pmRNSNotice of Results
16th Jan 20157:00 amRNSTrading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.